Alkaptonuria is a novel human secondary amyloidogenic disease - Wikidata - wikimedia - TriplyDB

Alkaptonuria is a novel human secondary amyloidogenic disease

Alkaptonuria is a novel human secondary amyloidogenic disease

http://www.wikidata.org/entity/Q37209177

about

Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient Neurological Assessment and Nerve Conduction Study Findings in 22 Patients with Alkaptonuria from Jordan ApreciseKUre: an approach of Precision Medicine in a Rare Disease.Diagnosis of secondary amyloidosis in alkaptonuria.The Pigment in Alkaptonuria Relationship to Melanin and Other Coloured Substances: A Review of Metabolism, Composition and Chemical Analysis Chondroptosis in alkaptonuric cartilage Redox proteomics gives insights into the role of oxidative stress in alkaptonuria.Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.Amyloidosis in alkaptonuria.Acute fatal metabolic complications in alkaptonuria.Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.Histological and Ultrastructural Characterization of Alkaptonuric Tissues.Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.Secondary amyloidosis in an alkaptonuric aortic valve.Angiogenesis in alkaptonuria.Cytoskeleton Aberrations in Alkaptonuric Chondrocytes.Single Amino Acid Substitution in Homogentisate Dioxygenase Affects Melanin Production in

P2860

Q28385838-E4F4BFEE-DD65-4B17-9351-F0A9BB49B075 Q33168287-A3338188-D887-4C7C-BB63-A988ABC66967 Q33564599-E94E5F77-E401-4F08-A04F-0A1185D1F737 Q34304026-2FC4AA21-C86E-484E-BB24-952CFBE61825 Q36090565-585A1432-2084-40DC-A5AA-BF5FC24179FA Q37257490-644C2231-6E8A-45AB-8350-B42461189DC1 Q38160929-FDFCD05E-72B4-40C0-8619-E6386D93CACB Q38414587-4D8792CE-A8C2-4370-8AFA-8A5A60BF30CD Q38418724-34187F3B-15DF-401D-BF77-717DF3146CAF Q38644004-3FA45B67-A1AF-4C73-B417-198E3E8AF4EC Q38900949-30FF9808-F8F4-4BAD-B4D5-54A3C81CB0EA Q38922014-21BC12F0-205C-4FF0-A8E7-B522E5C6F8FA Q39147959-8694FED2-4F4B-4A6E-B9E7-63DC104494E6 Q42345009-3955B297-2781-40E1-95E3-FF38E0F58B92 Q48334228-8C5E1DFC-68EE-41F3-8A5B-AAE8B5E042EC Q51618833-4D0E51EC-1CD0-4A16-97DE-1001E4719CE0 Q58573048-87833F6C-629F-4A8D-B58B-5BAB58C5056F

P2860

Alkaptonuria is a novel human secondary amyloidogenic disease

http://www.wikidata.org/entity/Q37209177

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 July 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Alkaptonuria is a novel human secondary amyloidogenic disease

@en

Alkaptonuria is a novel human secondary amyloidogenic disease.

@nl

type

label

Alkaptonuria is a novel human secondary amyloidogenic disease

@en

Alkaptonuria is a novel human secondary amyloidogenic disease.

@nl

prefLabel

Alkaptonuria is a novel human secondary amyloidogenic disease

@en

Alkaptonuria is a novel human secondary amyloidogenic disease.

@nl

P1433

Q37209177-0482A892-86C4-4D7D-9041-DF0DFA606E6C

P1476

Q37209177-045A6958-47B5-4C64-9D9F-5B357324C556

P2093

Q37209177-11877BB7-F7F7-4C2C-AFE2-7350FF2F3ECA

Q37209177-314B8EEA-13C0-4BB1-BBF8-AA7D15AC2FF5

Q37209177-38ECC6D2-21A7-412B-A6CF-685A720F09E7

Q37209177-436552D8-C076-47DD-AF14-CD8C3A2BFC56

Q37209177-52FCDFD2-3F00-49A4-B856-FDC95B99A78C

Q37209177-62290D51-E1C1-4257-B477-1A997B4D04A0

Q37209177-6568E9BC-5B48-4D5B-83B7-1B05A43EC005

Q37209177-6D82C34C-1A4E-46D6-A772-1C734DB96A34

Q37209177-72C8CB41-7A71-475D-8D89-252F21BF2572

Q37209177-7BED7830-C5EB-4227-90CF-4CC87A54E377

P2860

Q37209177-01A357E0-E2BB-491C-8414-2CB44F218EE4

Q37209177-0466DF04-710F-418E-AC65-00E65F5F97A2

Q37209177-13F631F8-49FE-41D2-936B-62E18B832288

Q37209177-16502333-C62D-43C8-801D-288D08A1274E

Q37209177-18099A11-D637-4491-A9EA-E6514B858A66

Q37209177-2B612DE6-9B78-48EB-B834-E4E0283F5263

Q37209177-2B893F57-5783-48EE-9C21-A6BD64A076A7

Q37209177-49FAD632-1592-43B2-959F-366B75FD28BC

Q37209177-4B700834-C804-442D-9390-33899C27D49B

Q37209177-4DC22D5A-FC69-4DFB-86AA-8E50D93EC109

P304

Q37209177-B8158565-B848-450F-B9F4-DA45BC4BCDBD

P31

Q37209177-C64A9284-44B6-4DBD-9F31-F436C180F133

P356

Q37209177-18DC7F04-F36B-4C7C-8166-E300918E81C0

P407

Q37209177-D7AA3D02-B516-4ED3-8622-15004C02B2AD

P433

Q37209177-CAE11E1C-B8D9-4D2E-9F0A-E187FF2F315C

P478

Q37209177-BFF04499-71D5-4F11-A783-CF73F142084D

P50

Q37209177-05AE81C7-226D-4619-90BE-ADDBFA07DC49

Q37209177-34184797-6FF2-495E-BAEB-32C89E6F1C7C

Q37209177-4725AB25-1423-464E-BEAE-AE39414AE68C

Q37209177-536D3150-F52F-4D1B-BF16-E03654A305FA

Q37209177-D8FA470C-97F2-4A41-83B9-B7F451D1815A

P577

Q37209177-35DEFCE0-5D67-4273-AFF2-C781427F69D5

P5875

Q37209177-5EF0A608-196E-4260-AC08-626A4D394DCD

P698

Q37209177-3904419F-3205-42B7-884C-1ED51E41C77D

P921

Q37209177-84464D70-C2B7-4D75-BE67-9C4795A685FC

P932

Q37209177-DDD1C88B-A23E-4A8A-876D-B6BD0E0A89C0

P356

J.BBADIS.2012.07.011

P1433

Biochimica et Biophysica Acta

P1476

Alkaptonuria is a novel human secondary amyloidogenic disease

@en

P2093

Alessandro Mannoni

http://www.w3.org/2001/XMLSchema#string

Enrico Selvi

http://www.w3.org/2001/XMLSchema#string

Federico Chellini

http://www.w3.org/2001/XMLSchema#string

Giulia Bernardini

http://www.w3.org/2001/XMLSchema#string

Laura Tinti

http://www.w3.org/2001/XMLSchema#string

Lia Millucci

http://www.w3.org/2001/XMLSchema#string

Loredana Amato

http://www.w3.org/2001/XMLSchema#string

Lorenzo Ghezzi

http://www.w3.org/2001/XMLSchema#string

Marcella Laschi

http://www.w3.org/2001/XMLSchema#string

Maurizio Benucci

http://www.w3.org/2001/XMLSchema#string

P2860

Functional amyloid formation within mammalian tissue.

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

Ca2+ binding by domain 2 plays a critical role in the activation and stabilization of gelsolin

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.

Natural history and outcome in systemic AA amyloidosis.

Proteomic evaluation and validation of cathepsin D regulated proteins in macrophages exposed to Streptococcus pneumoniae

Amyloid as a natural product.

Biochemical and proteomic characterization of alkaptonuric chondrocytes.

Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference.

Alkaptonuria--a review of surgical and autopsy pathology.

P304

1682-1691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBADIS.2012.07.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

1822

http://www.w3.org/2001/XMLSchema#string

P50

Annalisa Santucci

Eugenio Paccagnini

Adriano Spreafico

Daniela Braconi

P577

2012-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230591842

http://www.w3.org/2001/XMLSchema#string

P698

22850426

http://www.w3.org/2001/XMLSchema#string

P921

homogentisic acid

P932

3787765

http://www.w3.org/2001/XMLSchema#string